Ultrasound Guided Ulnar Versus Radial Artery in Pediatrics Undergoing Major Non Cardiac Surgery

NCT ID: NCT05771935

Last Updated: 2024-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-05

Study Completion Date

2023-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess the safety and efficacy of ulnar artery cannulation compared to radial artery cannulation in pediatrics undergoing major non cardiac procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a double blinded randomized controlled trial that will be conducted at Abu Al Reesh Children's Hospital, Faculty of Medicine, Cairo University after approval of research and ethics committees.

Children will be recruited into the trial during pre-operative assessment. will be randomly assigned to one of two groups Recruited patients will be randomly allocated by a computer-generated sequence of codes using randomization software (https://www. randomizer.org) into one of the two groups; in a 1:1 ratio (Group R) to receive radial artery cannulation and (Group U) to receive ulnar artery cannulation using ultrasound. The randomization sequence will be concealed in sequentially numbered, sealed opaque envelopes. The sealed envelopes will be opened by an anesthesia nurse immediately before induction of anesthesia.

After induction of anesthesia, modified Allen's test will be done by the ultrasound operator as following:

An Esmarch bandage will be used to exsanguinate the selected hand for cannulation according to the operator preference for 30 seconds, then the operator will apply simultaneous pressure to the ulnar and radial arteries of the chosen limb to occlude them. The bandage will then be released. Next, the pressure over the opposed artery selected for cannulation will be released and the time (in seconds) it takes for color to return to the hand will be measured.

Allen test results will be interpreted as follows:

If color returns to the hand within 5 seconds, the result of the Allen test is negative (normal) and the artery can safely be cannulated.

If color does not return to the palm within 5 seconds, the test result is positive (abnormal). The test will be repeated on the other hand and if the test is positive another site will be selected for cannulation, and the patient will be excluded from the study.

The patient's wrist will be extended over a roll to keep the angle of the wrist unchanged to 30- 45 degrees. After hand washing and sterile gloving; skin will be prepared using alcohol-based chlorhexidine antiseptic in both groups.

Assessment of proposed artery for cannulation using ultrasonography will be performed by one of 2 pediatric anesthesiologists blinded to group allocation who have performed more than 50 ultrasound guided arterial cannulation in pediatrics.

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

Image depth will be set to 2- 3 cm and gain settings adjusted to enhance views. Both external force and the angle will be manipulated to optimize images.

The radial artery will be identified in the transverse plane and confirmed with color flow doppler, then in the longitudinal plane by rotating the probe 90 degrees clockwise while maintaining the arterial image. This method will be repeated for the ulnar artery. All antro-posterior (AP) and transverse (T) diameters will be made at the inner (intimal) edge of the vessel. AP diameter will be measured on both transverse and longitudinal images. Cross-sectional area (CSA) will be calculated then as following: π \[AP × T\] /4. Three measurements will be collected, and the average values will be used for analysis.

Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae (Euromed For Medical Industries, S.A.E., Cairo, Egypt) according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study. The overall procedure time of arterial cannulation is defined as the time interval from the first skin puncture by the canula to confirmation of the arterial waveform on the monitor. After the procedure, the diameter of the cannulated artery and the occurrence of hematoma or vasospasm will be evaluated with ultrasound. Data will be collected by another anesthesiologist who is blinded to the group allocation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Pediatrics Radial Artery Ulnar Artery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

(Group R)

receive radial artery cannulation using ultrasound

Group Type EXPERIMENTAL

ultrasound guided radial versus ulnar artery cannulation

Intervention Type PROCEDURE

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

. Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study.

(Group U)

receive ulnar artery cannulation using ultrasound

Group Type ACTIVE_COMPARATOR

ultrasound guided radial versus ulnar artery cannulation

Intervention Type PROCEDURE

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

. Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound guided radial versus ulnar artery cannulation

Ultrasound examination will be performed using a hockey stick, high frequency (5-10 MHz) ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

. Arterial cannulation will be performed using the long axis view (in-plane) technique with a 24 or 22-gauge canulae according to the operator preference. Cannulation will be considered complete when the arterial waveform is confirmed on the monitor. If cannulation is unsuccessful within the third attempt or within 10 min, the case will be considered a failure at the chosen artery. After the failure, an alternative site will be used for cannulation and the case will be excluded from the study.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All pediatrics ASA I\&II aged 1 month -10 years undergoing major non cardiac surgeries.

Exclusion Criteria

* • Patients undergoing cardiac surgeries.

* Refusal of parents.
* Ischemia defined as (color changes: blanching, duskiness, and or change in temperature of the extremity used for cannulation compared to the contralateral one).
* Previous arterial cannulation within last week.
* Patients requiring inotropic support before the start of procedures.
* Rash or signs of infection or hematoma at the site of cannulation.
* Patients requiring emergency procedures.
Minimum Eligible Age

1 Month

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Khaled Abdelfattah Abdallah Sarhan

principal investigator,Lecturer of anesthesia, Cairo university

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo university hospitals, kasralainy

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS-225-2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AIN Transfer for Cubital Tunnel Syndrome
NCT05242302 COMPLETED PHASE1/PHASE2